At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Innovativ supportedother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medico-economic Assessment of a "IsereADOM" Package of Services Versus Conventional Monitoring in the Care of a Population of Frail Elderly People With Loss of Autonomy.
In Brief
A clinical study evaluating Innovativ supported for Fall Patients. Completed, enrolled 14 participants across 3 sites.
Detailed Summary
The goal of this study is to evaluate the effectiveness of the IsereADOM service package compared to conventional follow-up on the risk of recurrence of falls at 6 months in frail elderly subjects. There is a medico-economic goal too, is to conduct a cost-utility analysis of the IsereADOM service bundle compared to conventional 6-month follow-up from the community perspective in the cheat population at risk of re-offending.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFall Patients
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedJun 2018
Primary CompletionApr 2019
Study CompletionOct 2019
TodayJul 2026
First PostedJun 4, 2018
Enrollment StartFeb 16, 2018
Primary CompletionApr 12, 2019
Study CompletionOct 12, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.1 years ago
Interventions
Innovativ supportedother
addition of connected tools and stronger accompaniment to prevent falls